Pre-diagnostic circulating untargeted metabolomics and risk of overall and clinically significant prostate cancer: a systematic review and meta-analysis

by Cyrus Huneycutt | Feb 2, 2026 | 0 comments

Submit a Comment Cancel reply

You must be logged in to post a comment.